Journal profile · Hematology
Blood Coagulation & Fibrinolysis
ISSN 0957-5235 · eISSN 1473-5733 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly · Founded 1990
Blood Coagulation & Fibrinolysis: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.04; JCR Q4 (journal website); hybrid open access; median 90 days to acceptance (93 articles, last 24 months); community-reported acceptance: easy; 64 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Blood Coagulation & Fibrinolysis is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Blood Coagulation and Thrombosis Mechanisms, Venous Thromboembolism Diagnosis and Management and Platelet Disorders and Treatments, together about 40.1% of its articles. Its main subfields are Hematology. (generated from OpenAlex topic counts and CAS ranking data)
The main objective was to describe the clinical manifestation and treatment, as well as laboratory characteristics of patients with AHA.
From the journal's Aims & Scope
Research area (LetPub): Hematology
Editor-in-chief Marian Rollins-RavalPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Blood Coagulation and Thrombosis MechanismsMedicine18%
- Venous Thromboembolism Diagnosis and ManagementMedicine11.1%
- Platelet Disorders and TreatmentsMedicine11%
- Hemophilia Treatment and ResearchMedicine9.5%
- Blood properties and coagulationMedicine8.7%
- Atrial Fibrillation Management and OutcomesMedicine4.4%
- Coagulation, Bradykinin, Polyphosphates, and AngioedemaMedicine4.3%
- Heparin-Induced Thrombocytopenia and ThrombosisMedicine4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · HEMATOLOGY · rank 87/103
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.04LetPub ·
- Impact factor (publisher)
- 1Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- SJR 2026-06
- 0.4LetPub ·
- SNIP 2026-06
- 0.5LetPub ·
- h-index
- 67LetPub ·
- h-index
- 93OpenAlex ·
- i10-index
- 2,252OpenAlex ·
- 2-year mean citedness
- 1.01OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 10.58%LetPub ·
Volume
- Articles per year
- 53LetPub ·
Articles by year OpenAlex count · 5,311 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 7 | 5 |
| 2025 | 64 | 9 | 43 |
| 2024 | 63 | 13 | 134 |
| 2023 | 85 | 11 | 269 |
| 2022 | 81 | 13 | 505 |
| 2021 | 112 | 15 | 611 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
90 daysMedian, submission to acceptance · P25–P75 40 days – 175 days
- Acceptance to online
- median 32 days (93 articles)
- Submission to online
- median 134 days
- Sample
- 93 articles with submission and acceptance dates (134 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1990
- ISSN
- 0957-5235
- Electronic ISSN
- 1473-5733
- Latest issue on the website
- Volume 37, Issue 6 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Blood Coagulation & Fibrinolysis
What CAS zone is Blood Coagulation & Fibrinolysis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Blood Coagulation & Fibrinolysis is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Blood Coagulation & Fibrinolysis?
The latest impact factor listed by LetPub is 1.04; CiteScore 2.3, h-index 93.
How long does peer review take at Blood Coagulation & Fibrinolysis?
Based on the dates recorded on 93 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 90 days (interquartile range 40–175 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Blood Coagulation & Fibrinolysis in?
The journal's website gives JCR Q4; by category, HEMATOLOGY Q4 (87/103). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Blood Coagulation & Fibrinolysis?
According to LetPub and DOAJ records, Blood Coagulation & Fibrinolysis is indexed in SCIE and Scopus.
Is Blood Coagulation & Fibrinolysis open access, and what is the APC?
Blood Coagulation & Fibrinolysis is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .